Abstract-Effect of methylmercury chloride
Methylmercury induces various neuro logical disturbances and behavioral changes in humans and experimental animals (1-4). The exact mechanism by which methyl mercury produces such neurotoxic effects remains unknown.
Previously, we reported that methyl mercury chloride (MMC) inhibited choline acetyltransferase (ChA) activity and high affinity uptake of choline into brain syn aptosomes in vitro (5), and that a chronic administration of MMC (5 mg Hg/kg/day for about 15 days) to mice decreased the acetylcholine (ACh) turnover and ACh level in some regions of the brain (6). A single administration of hemicholinium-3 (HC-3, a potent inhibitor of high affinity choline uptake) or 3'-chloro-4-stilbazole (CS, a potent inhibitor of ChA) selectively decreased the ACh turnover and ACh level in the brain of mice (6).
To clarify the correlation between the alteration in cholinergic parameters and methylmercury neurotoxicity, studies were conducted on the behavior of mice. It was reported that chronic intoxication of methyl mercury induced irreversible morphological and biochemical changes in nervous tissue, especially in later stages of poisoning (3, 7, 8). As it is impossible to eludicate directly a correlation between changes in behavior and those in the cholinergic system only by assessing the effects of methylmercury on this system in vitro or in vivo, an investigation of the behavior of animals administered drugs which have an effect on this system similar to that of methylmercury, but which are reversible should provide pertinent infor mation. For this reason, CS and HC-3 were selected as reference drugs to separate cholinergic features from induced behavioral changes.
Although no specific behavior reflects the central cholinergic function (9, 10), simple methods such as spontaneous motor activity, body temperature and rotarod test, may be applicable (9-12).
The present study was carried out, with CS and HC-3 as reference drugs, to examine the effect of MMC on behavior of mice repeatedly exposed to this compound.
MATERIALS AND METHODS
Animals: Male ICR-JCL mice (4-6 weeks of age at the beginning of experiment) were housed in groups of five each in 20x30x10 cm aluminum cages with a wire-mesh bottom and were allowed to have free access to food and water, except during the behavioral testing, and kept in light for 12 hr (7-19 h) and in darkness for 12 hr in a room at 25±1 °C.
Behavioral testing: Behavioral testing were conducted between 10:00 am and 4:00 pm.
The spontaneous motor activity of an individual mouse was determined for 10 min using an Electron Motility Meter 40 FC (Motron Products, Stockholm) which was located in a dimly lit, soundless room. This apparatus had a 20x32 cm area illuminated from above with a 60 w fluorescent lamp. One minute after placing a mouse near the center of the area, the motor activity of the mouse was recorded for 10 min and was expressed as percent of the pre-injection (100%) count.
Immediately after recording the spon taneous motor activity, the rectal temperature of the mouse was measured by a Telether mometer (Natsume, model KN-90) at a constant ambient temperature (25±1 °C) and was read 30 sec after insertion of the probe 2.8 cm deep into the rectum. The rectal temperature change was expressed in centigrade different from the pre-injection value of each mouse.
Soon after recording the rectal temperature, the rotarod testing was performed by a Rota Rod (Natsume, model KN-75). Mice were placed on a rod (30 mm in diameter) rotating at 5.5 rpm. One day prior to the first behavioral testing, mice were so trained that they could stay on the rod for longer than 180 sec. When they could stay on the rod for 180 sec in the 1st or 2nd trial, they were given a score of 180. When they were unable to cling to the rod for 180 sec until the 3rd trial, or when they succeeded in staying on the rod for 180 sec only in the 3rd trial, they were assigned a score which was the mean value of the three trials.
Administration of MMC, CS, and HC-3: MMC in a dose of 5 mg/kg of Hg was administered i.p. once daily between 5:00 pm and 6:00 pm, as described previously (6). The administration was stopped when weight loss exceeded one gram per day. Control animals were given daily 0.1 ml of sterile physiological saline per 10 g of BW.
A single dose of CS, such as 100 and 200 mg/kg, was given i.p. as described previously (6). Control animals were given a mixture of NaCI-propylene glycol (7:3 for 200 mg/kg or 17:3 for 100 mg/kg of CS).
HC-3 was given intracerebrally by the method of Haley and McCormick (13) 
RESULTS
Effects of MMC on body weight gain, spontaneous motor activity, rectal temper ature and rotarod performance: The control animals given 0.9% NaCI continued to gain in body weight throughout the experimental period (Fig. 1) . The mice given MMC consecutively exhibited a loss in body weight by more than 1 g per day 18.0±1.2 (SE) days after the first administration (Fig.  1) . MMC-injection was discontinued when the mice showed more than 1 g loss in body weight, after which there was a progressive loss in body weight. Finally, death occurred on the 24th day after the first injection. Figure 2 shows changes in spontaneous motor activity expressed as percent of each naive activity of the control and MMC treated mice. The mean count of motor activity for 10 min of each naive mouse was 45.7±2.6 (SE, n=10) for the control group and 50.3±3.6 for the MMC group. There was no significant difference in the activity between the two groups.
The control mice showed a relatively constant activity, except for an initial transient decrease during the first five days.
On the other hand, the MMC group showed a progressive decrease in motor activity which was significantly different from the control value on the 1 2th day. While the control mice did not show a decrease in activity of less than 50% of the original level, the MMC group showed an activity consistently lower than 50%. Thus, the change in spontaneous motor activity appeared about 6 days earlier than the statistically significant body weight loss. This hypothermia was always observed one day or more earlier than the loss in body weight. The rotarod performance of the MMC group (0) and the control group (0) was conducted on the rod rotating at 5.5 rpm. A mouse was given a score of 180 when it could stay on the rod for 180 sec in the 1st or 2nd trial, and a score of a mean value of three trials when it could stay for less than 180 sec in anyone of the three trials or for 180 sec in the 3rd trial. The value represents a mean score in per formance±SE (n=10, at each point, unless otherwise stated).
For further information see the legend of Fig. 1 .
Rotarod performance data are shown in Fig. 4 . The control mice always scored 180 throughout the experimental period. On the other hand, decreases were significant in the MMC group on the 15th day after the first injection. This decrease occurred about 3 days earlier than that in body weight.
Behavioral changes induced by MMC in mice are summarized in Table 1 . As reported previously (6), mice showed overt signs, such as depression, staggering gait in walking, abnormal posture, and hind limb flexion or crossing when held by the tail, over a period from about 19th to 24th day after the first injection of MMC in this experiment.
Effect of CS on spontaneous motor activity, rectal temperature, and rotarod performance: Mice were given a dose of 100 or 200 mg/kg of CS and examined for changes in behavior 1, 3, 5 and 24 hr later (Fig. 5 A-C) .
Regardless of the dose of CS, spontaneous motor activity decreased markedly 1, 3 and 5 hr after the injection (Fig. 5A) . Recovery was still incomplete at 24 hr, although the behavior was much the same as in the untreated animals. In the control mice, spontaneous motor activity decreased 50% in just one day and remained constant thereafter.
Both doses of CS induced a remarkable fall in rectal temperature 1 to 5 hr after administration (Fig. 5B) . Recovery in the temperature was still incomplete 24 hr after the injection. Changes in the temperature of both controls were within a range of ±1 °C throughout the experimental period.
Both doses of CS caused an impairment in the rotarod performance of mice 1, 3 and 5 hr after the injection (Fig. 5C ). The performance remained at 180 in the control mice throughout the experimental period.
Effects of HC-3 on spontaneous motor activity, rectal temperature, and rotarod performance: The effect of an intracerebral dose of 51 or 100 ag/kg of HC-3 on the behavior of mice was determined (Fig. 6A-C) .
There was no significant difference in motor activity between the mice treated with HC-3 and the control mice (Fig. 6A) . Even the control mice showed a progressive decrease in such activity. Intracerebral administration of 51 or 100 ,ag of HC-3 induced a fall in rectal temperature 40 min after the injection. The temperature returned to almost the normal level 180 min later (Fig. 6B) . The change in the temper ature was within a range of ±1 °C in the control mice throughout the experimental period. The spontaneous motor activity (A) of mice was determined for 10 min and expresses as mean percent of pretreatment activity (100%). The mean change in the rectal temperature (B) of mice was expressed as a difference (T°C) from pretreatment temper ature. The rotarod performance (C) of mice was conducted on the rod rotating at 5.5 rpm and scored as mentioned in Fig. 4 . Each point and vertical bar represent a mean±SE (n=10). Fig. 6 . Effects of HC-3 on spontaneous motor activity, rectal temperature, and rotarod per formance.
• HC-3 (51 ug/kg, n=10); 0 HC-3 (100 pg/kg, n=10); 0 Control (n=10). The spontaneous motor activity (A) of mice was determined for 10 min and expressed as mean percent of pretreatment activity (100%). The mean change in the rectal temperature (B) of mice was expressed as a difference (T°C) from pretreatment temperature.
The rotarod perfor mance (C) of mice was conducted on the rod rotating at 5.5 rpm and scored as mentioned in Fig. 4 . Each point and vertical bar represent a mean±SE (n=10).
Injection of a dose of 51 or 100 ug/kg of HC-3 resulted in impairment of the rotarod performance.
This effect reached a peak 40 min after the injection.
The performance increased to almost the normal level by 250 min after the injection.
The control mice showed no changes in the rotarod perfor mance throughout the experimental period. [16] [17] [18] . Here, the activity was the earliest of all the changes in behavior. It also decreased considerably over a period of 1 to 5 hr after a single injection (100 or 200 mg/ kg) of CS. It was reported that CS at a dose of 200 mg/kg or more induced overt signs such as depression and motor in coordination, in mice (6, 19) .
Intracerebral injection of a dose of 51 or 100 fig/kg of HC-3 induced a progressive decrease in spontaneous motor activity. Such decrease was also evident in control mice given only physiological saline.
Thus, it can be speculated that behavioral changes observed prior to the manifestation of overt signs may be attributed preferentially to biochemical changes, rather than mor phological ones, in the nerve cells. In the present experiment, changes in behavior observed prior to the manifestation of overt signs, and of a similar nature with CS and HC-3, the influences of which are reversible, might be attributed mainly to biochemical changes in the neurotransmitter and non transmitter systems, but not to irreversible morphological changes.
Although MMC and the reference drugs, CS and HC-3, showed a different time course of behavioral changes and the site of action differed, their gross effects were similar and in the same direction. In addition to previous findings (6) in which MMC had effects similar to those seen with CS and HC-3 on the brain cholinergic system in mice, there was a similarity in behavioral changes after dosing with MMC and CS or HC-3. These relationships are summarized in Table 1 .
On the basis of the findings described above, it is highly probable that central cholinergic dysfunction may be involved at least in the early stage of chronic intoxication of methylmercury. 
